NEUROONE MEDICAL TECHNOLOGIES CORPORATION

NeuroOne Medical Technologies Corporation

NMTC

US64130M2098

Advanced Medical Equipment & Technology

Delayed Nasdaq Other stock markets 13:26:14 2024-05-23 EDT			5-day change	1st Jan Change
1.06 ^USD	0.00%		0.00%	-33.54%

05-14	Transcript : NeuroOne Medical Technologies Corporation, Q2 2024 Earnings Call, May 14, 2024
03-26	NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System	CI

NeuroOne Medical Technologies Corporation Ends the Employment of Thomas Bachinski, Chief Development Officer

August 05, 2019 at 04:33 pm

On July 30, 2019, NeuroOne Medical Technologies Corporation ended the employment of Thomas Bachinski, Chief Development Officer of the Company, effective July 30, 2019.

Latest news about NeuroOne Medical Technologies Corporation

Transcript : NeuroOne Medical Technologies Corporation, Q2 2024 Earnings Call, May 14, 2024	05-14
NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System	03-26	CI
Transcript : NeuroOne Medical Technologies Corporation, Q1 2024 Earnings Call, Feb 13, 2024	02-13
NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	02-13	CI
Transcript : NeuroOne Medical Technologies Corporation, Q4 2023 Earnings Call, Dec 14, 2023	12-14
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Full Year Ended September 30, 2023	12-14	CI
NeuroOne Gets FDA Clearance to Market OneRF Ablation System; Shares Fall	12-11	MT
NeuroOne Medical Technologies Corporation Receives FDA 510(K) Clearance to Market its OneRF(TM) Ablation System	12-11	CI
NeuroOne Medical Technologies Gets Notice of Allowance for Drug Delivery Patent	11-16	MT
NeuroOne Medical Technologies Corporation Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe	11-16	CI
NeuroOne Medical Technologies Names Christopher Volker as Chief Operating Officer	11-15	MT
NeuroOne Medical Technologies Corporation Appoints Christopher R. Volker as Chief Operating Officer	11-14	CI
NeuroOne Medical Technologies Corporation Provides Progress Update on FDA 510(k) Submission for OneRF?? Ablation System	11-07	CI
Alliance Global Partners Trims Price Target on NeuroOne Medical Technologies to $2.20 From $3.25, Maintains Buy Rating	23-08-15	MT
Transcript : NeuroOne Medical Technologies Corporation, Q3 2023 Earnings Call, Aug 14, 2023	23-08-14
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-14	CI
Top Midday Decliners	23-07-25	MT
Top Premarket Decliners	23-07-25	MT
NeuroOne Medical Technologies Proposes Common Stock Offering -- Shares Sink Premarket	23-07-25	MT
NeuroOne Medical Technologies Shares Rise 4.9% After 510(k) Submission	23-06-12	DJ
NeuroOne Medical Technologies Corporation Submits 510(K) Application to FDA for OneRF™ Ablation System	23-06-12	CI
NeuroOne Medical Technologies Corporation Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery	23-05-17	CI
Transcript : NeuroOne Medical Technologies Corporation, Q2 2023 Earnings Call, May 11, 2023	23-05-11
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-11	CI
Top Premarket Gainers	23-04-12	MT

Chart NeuroOne Medical Technologies Corporation

Duration

Period

Chart NeuroOne Medical Technologies Corporation

More charts

NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-26 - H.C. Wainwright Neuro Perspectives Virtual Conference

More about the company

	1st Jan change	Capi.
NEUROONE MEDICAL TECHNOLOGIES CORPORATION	-33.54%	27.49M
SARTORIUS AG	-21.31%	17.75B
QUIDELORTHO CORPORATION	-42.96%	2.85B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.67%	1.92B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-7.25%	1.58B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-18.78%	952M
CONTEC MEDICAL SYSTEMS CO.,LTD	-24.92%	888M
REVENIO GROUP OYJ	+4.64%	828M
VAREX IMAGING CORPORATION	-28.27%	611M
CELLAVISION AB	+19.10%	591M

Medical Diagnostic & Testing Equipment